Virtual Symposium (Expired): The New Face of Lipid Management for Patients with Hypercholesterolemia and Statin Intolerance

This activity is designed to update clinicians on the identification and diagnosis, as well as current guidelines and emerging algorithms for the treatment of statin intolerant patients. The efficacy and safety of current and emerging therapies for statin intolerant patients will also be reviewed during the activity. Expert faculty will discuss the true incidence and diagnostic criteria of statin intolerance, the mechanistic rationale for lowering LDL-C through PCSK9 inhibition and other novel targets/pathways, treatment strategies, and where emerging therapies fit into current treatment guidelines and algorithms. Finally, experts will provide practical clinical perspectives on a statin intolerant patient case. This activity is expected to improve lipid management of patients at increased ASCVD risk, particularly those with statin intolerance.

Opening Remarks; Practical Strategies for Identifying and Diagnosing Statin Intolerant Patients

Faculty: Robert H. Eckel, MD

Management of Statin Intolerant Patients with Current Therapies for Hypercholesterolemia

Faculty: Steven E. Nissen, MD, MACC

Emerging Hypercholesterolemia Therapies for Statin Intolerant Patients

Faculty: Michael H. Davidson, MD*

Audience Q&A

Presenter: All Faculty

Evidence to Practice Expert Roundtable: Case Study and Panel Discussion

Presenter: All Faculty